Business · 19/02/2014
FDA Reschedules Public Meeting on Fibromyalgia Patient-Focused Drug Development
The FDA is rescheduling a public meeting on Patient-Focused Drug Development for fibromyalgia, originally set for December 10, 2013, due to inclement weather, and extending the comment period for the public docket.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →